Arcadia Biosciences (RKDA) Misses Q1 EPS by 3c

Arcadia Biosciences (NASDAQ: RKDA) reported Q1 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.02 million versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
• L&T Financial Holdings (LTFH:IN) PT Raised to INR380 at Axis Capital Limited